NL-OMON45561已完成不适用
Quantitative kinetic analysis of [11C]DPA-713 and [18F]PEG-Folate uptake in joints of patients with rheumatoid arthritis - [11C]DPA-713 and [18F]PEG-Folate in rheumatoid arthritis
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •* Men and women, * 18 years of age.
- •* Diagnosis of rheumatoid arthritis according to the 1987 revised criteria of the American Rheumatism Association (ARA) and/or the 2010 ACR/EULAR Rheumatoid Arthritis Classification Criteria.
- •* Patients with obvious clinical arthritis activity assessed by a physician, in at least 1 hand, wrist of knee joints.
- •* Treatment with disease modifying anti-rheumatic drugs (DMARDS), biologics and oral corticosteroids up to 10 mg daily is allowed. Non-steroidal anti-inflammatory drugs (NSAID) is permitted, provided that there is a stable dose for at least 1 month.
- •* Patients must be able to adhere to the study appointments and other protocol requirements.
- •* Patients must be capable of giving informed consent and the consent must have been obtained prior to the study related procedures.
排除标准
- •* Use of intramuscular or intravenous corticosteroids within 4 weeks prior to screening.
- •* Treatment with any investigational drug within the previous 3 months.
- •* Pregnancy or breast-feeding
- •* Anemia (Hemoglobine <6.0 mmol/L)
- •* Renal insufficiency (GFR <30 mL/min/1.73m2)
研究者
相似试验
已完成
不适用
Plasma kinetic of the concentration of D9- and D3-choline and their metabolites in the plasma of male adults after administration of four D9-marked choline supplementsE63.8Other specified nutritional deficienciesDRKS00020498niversitätsklinikum Tübingen6
进行中（未招募）
1 期
This is a study to evaluate a radioactive agent that detects tau protein in the brains of people with thinking problems and normal peopleMedDRA version: 18.0Level: HLTClassification code 10001897Term: Alzheimer's disease (incl subtypes)System Organ Class: 100000004852Alzheimer's diseaseEUCTR2014-003047-35-NLAvid Radiopharmaceuticals, Inc.22
已完成
2 期
Evaluation of 18F-AV-1451 kinetic modeling in patients in Alzheimer's disease and healthy controlsdementiaAlzheimer's DiseaseNL-OMON44604Avid Radiopharmaceuticals20
进行中（未招募）
1 期
A Phase III Study of [11C]-DMDPA Tracer for Positron Emission Tomography PET-CT Myocardial Perfusion Imaging (MPI).Known or suspected acute coronary syndromeMedDRA version: 20.0Level: PTClassification code 10011078Term: Coronary artery diseaseSystem Organ Class: 10007541 - Cardiac disordersEUCTR2021-002557-29-PLSynektik Spólka Akcyjna350
已完成
不适用
Improving the diagnosis of liver cancer with Positron Emission Tomography (PET) scanners by applying mathematical models and using breathing motion correction methodsCancer - Bowel - Back passage (rectum) or large bowel (colon)Colon cancerACTRN12610000747022Paul Thomas10